QELBREE XR Trademark

Trademark Overview

On Monday, November 18, 2019, a trademark application was filed for QELBREE XR with the United States Patent and Trademark Office. The USPTO has given the QELBREE XR trademark a serial number of 88696465. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 22, 2022. This trademark is owned by Supernus Pharmaceuticals, Inc.. The QELBREE XR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
qelbree xr

General Information

Serial Number88696465
Word MarkQELBREE XR
Filing DateMonday, November 18, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 22, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
Disclaimer with Predetermined Text"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSupernus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameSupernus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, August 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 22, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 21, 2022SOU EXTENSION 3 GRANTED
Friday, January 21, 2022SOU EXTENSION 3 FILED
Friday, January 21, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 21, 2021SOU EXTENSION 2 GRANTED
Wednesday, July 21, 2021SOU EXTENSION 2 FILED
Wednesday, July 21, 2021SOU TEAS EXTENSION RECEIVED
Saturday, January 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2021SOU EXTENSION 1 GRANTED
Thursday, January 21, 2021SOU EXTENSION 1 FILED
Thursday, January 21, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 22, 2020ASSIGNED TO LIE
Monday, April 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 13, 2020EXAMINER'S AMENDMENT ENTERED
Monday, April 13, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 13, 2020EXAMINERS AMENDMENT E-MAILED
Monday, April 13, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, February 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 28, 2020NON-FINAL ACTION E-MAILED
Friday, February 28, 2020NON-FINAL ACTION WRITTEN
Friday, February 21, 2020ASSIGNED TO EXAMINER
Saturday, November 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 21, 2019NEW APPLICATION ENTERED

Related Keywords

qelbree diseases system nervous disorders neurological peripheral psychiatric central therapeutic preparations